v3.25.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 2,601,122 2,194,513
General and administrative 681,210 342,688
Total operating expenses 3,282,332 2,537,201
Loss from operations (3,282,332) (2,537,201)
Interest income 23,970 64,006
Net loss $ (3,258,362) $ (2,473,195)
Per share information:    
Net loss per common share, basic $ (0.25) $ (0.19)
Net loss per common share, diluted $ (0.25) $ (0.19)
Weighted average common shares outstanding, basic 13,171,555 12,859,685
Weighted average common shares outstanding, diluted 13,171,555 12,859,685